\n\n\n\n\t\t\n\t\t\tHansen Medical\n\t\t\thttp://www.hansenmedical.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tHansen Medical, Inc. (NASDAQ:HNSN), develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first...More»
\n\t\t\tHansen Medical, Inc. (NASDAQ:HNSN), develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei(TM) Robotic Catheter system, is a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability during complex cardiac arrhythmia procedures. The Sensei system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data and was cleared by the U.S. Food and Drug Administration (FDA) in May 2007 for manipulation and control of certain mapping catheters in Electrophysiology (EP) procedures. The safety and effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including AF, have not been established. In the European Union, the Sensei system is cleared for use during EP procedures«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tMt. View, CA, United States\n
\n\t\t\t\tIndustry: Medical Devices & Equipment
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\tbiotech,\n\t\t\t\tcadiac,\n\t\t\t\thansen medical,\n\t\t\t\trobots,\n\t\t\t\tautomated,\n\t\t\t\tHNSN,\n\t\t\t\tcatheter\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series C - $30M (11/17/2005)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tDe Novo Ventures,\n\t\t\t\t\t\n\t\tProspect Venture Partners,\n\t\t\t\t\t\n\t\tSapient Capital,\n\t\t\t\t\t\n\t\tSkyline Ventures,\n\t\t\t\t\t\n\t\tThomas Weisel Partners,\n\t\t\t\t\t\n\t\tVanguard Venture Partners\n\t\t\t\t
\n\t\t\t